Keywords: Abbott, Meridia, Public Citizen, USA, Obesity, Sibutramine

USA’s Public Citizen again calls for a ban on Abbott’s obesity drug Meridia

Article | 4 December 2009

• Print This

New research shows that drug major Abbott Laboratories Meridia (sibutramine), a popular weight-loss drug, has caused a significantly increased number of heart attacks, strokes, resuscitated cardiac arrests or deaths in obese patients getting the drug and should, therefore, be pulled from the market immediately, claims the US advocacy group Public Citizen, in a petition to the Food and Drug Administration yesterday.

This is Public Citizen’s second appeal to have Meridia banned; the FDA rejected the first four years ago, saying it was awaiting results of an ongoing trial. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.